» Articles » PMID: 20029200

MicroRNAs MiR-1, MiR-133a, MiR-133b and MiR-208 Are Dysregulated in Human Myocardial Infarction

Overview
Journal Cardiology
Date 2009 Dec 24
PMID 20029200
Citations 152
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: MicroRNAs (miRNAs) are noncoding single-stranded RNA molecules that regulate gene expression in physiological functions, development and disease. In recent studies, three miRNAs have been described as muscle or cardiac specific: miR-1, miR-133, and miR-208, being involved in heart development and disease; but there are limited data on their role in human myocardial infarction (MI). We therefore analyzed their expression in human MI.

Methods: Autopsy samples of infarcted heart tissue from 50 patients with MI, 8 healthy trauma victims and 9 fetuses that died in utero were included. miRNAs miR-1, miR-133a/b and miR-208 were analyzed using quantitative real-time polymerase chain reaction.

Results: miR-208 was upregulated, whereas miR-1 and miR-133a were downregulated in MI compared to healthy adult and fetal hearts. All four tested miRNAs were downregulated in fetal hearts compared to healthy adult hearts.

Conclusions: Our study showed the involvement of muscle- and/or cardiac-specific miRNAs miR-1, miR-133a/b and miR-208 in human MI. The most significant finding was upregulation of miR-208 and downregulation of miR-1 and miR-133a in MI compared to healthy adult hearts. Some patterns of miRNA expression were similar in MI and fetal hearts, supporting the concept of cardiac gene reprogramming in the remodeling of the heart.

Citing Articles

The Potential Contribution of MyomiRs miR-133a-3p, -133b, and -206 Dysregulation in Cardiovascular Disease Risk.

Crocco P, Montesanto A, La Grotta R, Paparazzo E, Soraci L, Dato S Int J Mol Sci. 2024; 25(23).

PMID: 39684483 PMC: 11641116. DOI: 10.3390/ijms252312772.


Global surveillance of circulating microRNA for diagnostic and prognostic assessment of acute myocardial infarction based on the plasma small RNA sequencing.

Wang X, Lu Y, Zhao R, Zhu B, Liu J, Yue Q Biomark Res. 2024; 12(1):143.

PMID: 39563415 PMC: 11577892. DOI: 10.1186/s40364-024-00690-x.


Mesenchymal stem cells as future treatment for cardiovascular regeneration and its challenges.

Seow K, Ling A Ann Transl Med. 2024; 12(4):73.

PMID: 39118948 PMC: 11304428. DOI: 10.21037/atm-23-1936.


Cardiovascular Disease and miRNAs: Possible Oxidative Stress-Regulating Roles of miRNAs.

Lee S Antioxidants (Basel). 2024; 13(6).

PMID: 38929095 PMC: 11200533. DOI: 10.3390/antiox13060656.


Detailed role of mesenchymal stem cell (MSC)-derived exosome therapy in cardiac diseases.

Hassanzadeh A, Shomali N, Kamrani A, Nasiri H, Heris J, Pashaiasl M EXCLI J. 2024; 23:401-420.

PMID: 38741729 PMC: 11089093. DOI: 10.17179/excli2023-6538.